A CME/CNE/CPE/MOC Activity
TO REGISTER:
Click here to complete your registration.
If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.
DATES AND TIMES
Thursday, November 19, 2020
4:00 - 5:00 PM ET (3:00 - 4:00 PM CT / 1:00 - 2:00 PM PT)
Wednesday, December 9, 2020
7:00 - 8:00 PM ET (6:00 - 7:00 PM CT / 4:00 - 5:00 PM PT)
Tuesday, December 15, 2020
1:00 - 2:00 PM ET (12:00 - 1:00 PM CT / 10:00 - 11:00 AM PT)
Tuesday, January 19, 2021
1:00 - 2:00 PM ET (12:00 - 1:00 PM CT / 10:00 - 11:00 AM PT)
AGENDA
Welcome and Introduction
Telemedicine in the Allergy/Immunology Practice
Guidance for Implementing Telemedicine for Patients with Asthma
Asthma Telemedicine: Navigating
the Legal and Regulatory Issues
Q&A Session
PROGRAM DESCRIPTION
Telemedicine
is becoming an increasingly common component of healthcare, driven by patient
demand and vast improvements in technology. While the integration of
telemedicine into daily practice in asthma management has been studied and
implemented to a limited extent over the last decade, many allergist and
immunologists have had the need for telemedicine thrust upon them very
suddenly. Thus, they lack
familiarity with the benefits of telemedicine and are likely uncertain on how
best to manage patient care in this virtual setting. Hence, these clinicians
will require education on best practices for incorporating telemedicine in the
asthma and allergist clinic, including different strategies for virtual
healthcare visits and remote patient monitoring, how to manage treatment in the
telemedicine setting, and how to navigate the complex and continuously evolving
legal and regulatory landscape pertaining to telehealthcare.
This program will provide clinicians with the most up-to-date information on
telemedicine in asthma care to promote easier transitions to this new and
necessary form of care for their patients.
STEERING COMMITTEEWanda Phipatanakul, MD, MS
Professor of
Pediatrics
Harvard Medical School
Director, Asthma Clinical Research Center
Boston Children's Hospital
Boston, MAJay M. Portnoy, MD
Professor of Pediatrics
University of Missouri-Kansas City School of Medicine
Staff Allergist and Medical Director of Telemedicine
Children’s Mercy Hospital
Kansas City, MOJodi
Shroba, MSN,
APRN, CPNP
Certified
Pediatric Nurse Practitioner
Food
Allergy Program Coordinator, Allergy Division
Children’s
Mercy Hospital
Kansas
City, MOAshley M. Thomas, PharmD, BCPS, BCACP, CACP
Clinical
Pharmacy Specialist, Primary Care
Nashville, TN
TARGET AUDIENCE
The intended audience for this educational initiative is primary care clinicians, allergists,
immunologists, pharmacists, nurses, and other healthcare providers involved in the care
of patients with asthma.
EDUCATIONAL OBJECTIVES
The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
This program is designed to address ACPE competencies, including foundational knowledge, essentials for practice and care, and approaches to practice and care.
At the conclusion of this education, participants should be able to:
PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit or the evaluation, please email contact@potomacme.org.
ABIM MOC DESIGNATION STATEMENT
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
PHARMACIST ACCREDITATION STATEMENT The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PHARMACIST CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-20-009-L01-P).
This is an
application-based activity.
For information about this continuing pharmacy education (CPE) activity, please email: contact@potomacme.org.
NURSING CREDIT STATEMENT
This nursing continuing professional development activity was approved by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
DISCLOSURE INFORMATION
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
Disclosures will be made known to the participants prior to the start of the activity.
FDA DISCLOSURE
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
SYSTEM CHECK
To ensure your computer is compatible for the live event, please perform a system check by clicking on the link http://livewebcast.net/test or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.
HARDWARE REQUIREMENTS
WINDOWS
MAC OS
MOBILE
SOFTWARE REQUIREMENTS
DSL/cable (wired connection recommended)
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/CE CREDIT AND MOC POINTS
There is no fee for this activity. To receive credit, participants must register, view the live CME/CE activity in its entirety, and then complete the post-test, with a score of 66% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
In collaboration with the American Lung Association
This program is supported by unrestricted educational grants from AstraZeneca, Sanofi Genzyme and Regeneron Pharmaceuticals.